SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Fulcrum Therapeutics, Inc. (FULC) News

Follow Fulcrum Therapeutics, Inc. (FULC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol FULC Asset equity Sector Markets 90 days 2 Last 3.69 Updated Nov 12, 2026, 09:13 PM UTC Open live news feed Open FULC chart & news
L Fulcrum Therapeutics Agrees to Sell HbF Assets for About $7 Million Fulcrum Therapeutics agreed to sell its early-stage fetal hemoglobin assets for approximately $7.0 million in cash. MNA | Nov 12, 2026, 09:13 PM UTC M Fulcrum Therapeutics Q3'26 Earnings Preview: EPS Estimate $(0.07) Fulcrum Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.07). EQUITY | Oct 28, 2026, 11:04 AM UTC M Fulcrum Therapeutics, Slate Medicines announce merger agreement Fulcrum Therapeutics and Slate Medicines announce a merger agreement to advance next-generation migraine therapies. MNA | Aug 17, 2026, 11:00 AM UTC L FULC: Block Trade FULC block trade of 640k shares at $3.60 EQUITY | Jun 18, 2026, 07:02 PM UTC